ICG Fluorescence Imaging in Trauma Patients

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 16, 2019

Primary Completion Date

November 23, 2021

Study Completion Date

November 18, 2022

Conditions
Trauma Injury
Interventions
OTHER

Immunofluorescence Imaging

Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Pentero or Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.

Trial Locations (1)

03756

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Dartmouth College

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT04245111 - ICG Fluorescence Imaging in Trauma Patients | Biotech Hunter | Biotech Hunter